Outcomes of tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a long-term follow-up of the randomized RIVETING trial

David T Rubin, Julian Panés, Joana Torres, Taku Kobayashi, Chinyu Su, Nervin Lawendy, Irene Modesto, Michelle Segovia, Sean Gardiner, Wenjin Wang, Séverine Vermeire

Open source

DOI: 10.1093/crocol/otag093
Published: 2026-07
Container: Crohn’s & Colitis 360
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/crocol/otag093,
  title = {Outcomes of tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a long-term follow-up of the randomized RIVETING trial},
  author = {David T Rubin and Julian Panés and Joana Torres and Taku Kobayashi and Chinyu Su and Nervin Lawendy and Irene Modesto and Michelle Segovia and Sean Gardiner and Wenjin Wang and Séverine Vermeire},
  year = {2026},
  journal = {Crohn’s \&amp; Colitis 360},
  doi = {10.1093/crocol/otag093},
  url = {https://doi.org/10.1093/crocol/otag093}
}

RIS

TY  - JOUR
TI  - Outcomes of tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a long-term follow-up of the randomized RIVETING trial
AU  - David T Rubin
AU  - Julian Panés
AU  - Joana Torres
AU  - Taku Kobayashi
AU  - Chinyu Su
AU  - Nervin Lawendy
AU  - Irene Modesto
AU  - Michelle Segovia
AU  - Sean Gardiner
AU  - Wenjin Wang
AU  - Séverine Vermeire
PY  - 2026
JO  - Crohn’s &amp; Colitis 360
DO  - 10.1093/crocol/otag093
UR  - https://doi.org/10.1093/crocol/otag093
ER  -

APA

Rubin, D. T., Panés, J., Torres, J., Kobayashi, T., Su, C., Lawendy, N., Modesto, I., Segovia, M., Gardiner, S., Wang, W., & Vermeire, S. (2026). Outcomes of tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a long-term follow-up of the randomized RIVETING trial. Crohn’s & Colitis 360. https://doi.org/10.1093/crocol/otag093

Source records

crossref · retrieved 2026-09-25T11:07:04.082Z